Development and Validation of an Efficient MRI Radiomics Signature for Improving the Predictive Performance of 1p/19q Co-Deletion in Lower-Grade Gliomas

The prognosis and treatment plans for patients diagnosed with low-grade gliomas (LGGs) may significantly be improved if there is evidence of chromosome 1p/19q co-deletion mutation. Many studies proved that the codeletion status of 1p/19q enhances the sensitivity of the tumor to different types of th...

Full description

Bibliographic Details
Main Authors: Quang-Hien Kha, Viet-Huan Le, Truong Nguyen Khanh Hung, Nguyen Quoc Khanh Le
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/21/5398
_version_ 1797512714728243200
author Quang-Hien Kha
Viet-Huan Le
Truong Nguyen Khanh Hung
Nguyen Quoc Khanh Le
author_facet Quang-Hien Kha
Viet-Huan Le
Truong Nguyen Khanh Hung
Nguyen Quoc Khanh Le
author_sort Quang-Hien Kha
collection DOAJ
description The prognosis and treatment plans for patients diagnosed with low-grade gliomas (LGGs) may significantly be improved if there is evidence of chromosome 1p/19q co-deletion mutation. Many studies proved that the codeletion status of 1p/19q enhances the sensitivity of the tumor to different types of therapeutics. However, the current clinical gold standard of detecting this chromosomal mutation remains invasive and poses implicit risks to patients. Radiomics features derived from medical images have been used as a new approach for non-invasive diagnosis and clinical decisions. This study proposed an eXtreme Gradient Boosting (XGBoost)-based model to predict the 1p/19q codeletion status in a binary classification task. We trained our model on the public database extracted from The Cancer Imaging Archive (TCIA), including 159 LGG patients with 1p/19q co-deletion mutation status. The XGBoost was the baseline algorithm, and we combined the SHapley Additive exPlanations (SHAP) analysis to select the seven most optimal radiomics features to build the final predictive model. Our final model achieved an accuracy of 87% and 82.8% on the training set and external test set, respectively. With seven wavelet radiomics features, our XGBoost-based model can identify the 1p/19q codeletion status in LGG-diagnosed patients for better management and address the drawbacks of invasive gold-standard tests in clinical practice.
first_indexed 2024-03-10T06:05:36Z
format Article
id doaj.art-7966f887deb047f0b8e1f2fea1c3d200
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T06:05:36Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-7966f887deb047f0b8e1f2fea1c3d2002023-11-22T20:34:40ZengMDPI AGCancers2072-66942021-10-011321539810.3390/cancers13215398Development and Validation of an Efficient MRI Radiomics Signature for Improving the Predictive Performance of 1p/19q Co-Deletion in Lower-Grade GliomasQuang-Hien Kha0Viet-Huan Le1Truong Nguyen Khanh Hung2Nguyen Quoc Khanh Le3International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, TaiwanInternational Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, TaiwanInternational Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, TaiwanInternational Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, TaiwanThe prognosis and treatment plans for patients diagnosed with low-grade gliomas (LGGs) may significantly be improved if there is evidence of chromosome 1p/19q co-deletion mutation. Many studies proved that the codeletion status of 1p/19q enhances the sensitivity of the tumor to different types of therapeutics. However, the current clinical gold standard of detecting this chromosomal mutation remains invasive and poses implicit risks to patients. Radiomics features derived from medical images have been used as a new approach for non-invasive diagnosis and clinical decisions. This study proposed an eXtreme Gradient Boosting (XGBoost)-based model to predict the 1p/19q codeletion status in a binary classification task. We trained our model on the public database extracted from The Cancer Imaging Archive (TCIA), including 159 LGG patients with 1p/19q co-deletion mutation status. The XGBoost was the baseline algorithm, and we combined the SHapley Additive exPlanations (SHAP) analysis to select the seven most optimal radiomics features to build the final predictive model. Our final model achieved an accuracy of 87% and 82.8% on the training set and external test set, respectively. With seven wavelet radiomics features, our XGBoost-based model can identify the 1p/19q codeletion status in LGG-diagnosed patients for better management and address the drawbacks of invasive gold-standard tests in clinical practice.https://www.mdpi.com/2072-6694/13/21/5398low-grade gliomasradiogenomicsmachine learningchromosome 1p/19q codeletionmolecular subtypewavelet transform
spellingShingle Quang-Hien Kha
Viet-Huan Le
Truong Nguyen Khanh Hung
Nguyen Quoc Khanh Le
Development and Validation of an Efficient MRI Radiomics Signature for Improving the Predictive Performance of 1p/19q Co-Deletion in Lower-Grade Gliomas
Cancers
low-grade gliomas
radiogenomics
machine learning
chromosome 1p/19q codeletion
molecular subtype
wavelet transform
title Development and Validation of an Efficient MRI Radiomics Signature for Improving the Predictive Performance of 1p/19q Co-Deletion in Lower-Grade Gliomas
title_full Development and Validation of an Efficient MRI Radiomics Signature for Improving the Predictive Performance of 1p/19q Co-Deletion in Lower-Grade Gliomas
title_fullStr Development and Validation of an Efficient MRI Radiomics Signature for Improving the Predictive Performance of 1p/19q Co-Deletion in Lower-Grade Gliomas
title_full_unstemmed Development and Validation of an Efficient MRI Radiomics Signature for Improving the Predictive Performance of 1p/19q Co-Deletion in Lower-Grade Gliomas
title_short Development and Validation of an Efficient MRI Radiomics Signature for Improving the Predictive Performance of 1p/19q Co-Deletion in Lower-Grade Gliomas
title_sort development and validation of an efficient mri radiomics signature for improving the predictive performance of 1p 19q co deletion in lower grade gliomas
topic low-grade gliomas
radiogenomics
machine learning
chromosome 1p/19q codeletion
molecular subtype
wavelet transform
url https://www.mdpi.com/2072-6694/13/21/5398
work_keys_str_mv AT quanghienkha developmentandvalidationofanefficientmriradiomicssignatureforimprovingthepredictiveperformanceof1p19qcodeletioninlowergradegliomas
AT viethuanle developmentandvalidationofanefficientmriradiomicssignatureforimprovingthepredictiveperformanceof1p19qcodeletioninlowergradegliomas
AT truongnguyenkhanhhung developmentandvalidationofanefficientmriradiomicssignatureforimprovingthepredictiveperformanceof1p19qcodeletioninlowergradegliomas
AT nguyenquockhanhle developmentandvalidationofanefficientmriradiomicssignatureforimprovingthepredictiveperformanceof1p19qcodeletioninlowergradegliomas